DE1493323A1 - 1,2-Diphenyl-3,4-dihydronaphthalenes and their acid addition salts and quaternary ammonium compounds - Google Patents
1,2-Diphenyl-3,4-dihydronaphthalenes and their acid addition salts and quaternary ammonium compoundsInfo
- Publication number
- DE1493323A1 DE1493323A1 DE19641493323 DE1493323A DE1493323A1 DE 1493323 A1 DE1493323 A1 DE 1493323A1 DE 19641493323 DE19641493323 DE 19641493323 DE 1493323 A DE1493323 A DE 1493323A DE 1493323 A1 DE1493323 A1 DE 1493323A1
- Authority
- DE
- Germany
- Prior art keywords
- acid
- radical
- phenyl
- lower alkyl
- acid addition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002253 acid Substances 0.000 title claims description 36
- 150000003839 salts Chemical class 0.000 title claims description 12
- 150000003856 quaternary ammonium compounds Chemical class 0.000 title claims description 4
- FRIGLBWVTJAEHM-UHFFFAOYSA-N 3,4-diphenyl-1,2-dihydronaphthalene Chemical class C1CC2=CC=CC=C2C(C=2C=CC=CC=2)=C1C1=CC=CC=C1 FRIGLBWVTJAEHM-UHFFFAOYSA-N 0.000 title description 3
- -1 alkenyloxy radical Chemical class 0.000 claims description 51
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 34
- 150000001875 compounds Chemical class 0.000 claims description 32
- 125000000217 alkyl group Chemical group 0.000 claims description 11
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- 229910052783 alkali metal Chemical group 0.000 claims description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 239000000460 chlorine Substances 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 125000003302 alkenyloxy group Chemical group 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 4
- 125000003342 alkenyl group Chemical group 0.000 claims description 4
- 125000004414 alkyl thio group Chemical group 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 239000011737 fluorine Substances 0.000 claims description 4
- 229910052731 fluorine Inorganic materials 0.000 claims description 4
- 239000007858 starting material Substances 0.000 claims description 4
- ROAOATHOCPRUKG-UHFFFAOYSA-N 4-(6-methoxy-2-phenyl-3,4-dihydronaphthalen-1-yl)phenol Chemical compound C1CC2=CC(OC)=CC=C2C(C=2C=CC(O)=CC=2)=C1C1=CC=CC=C1 ROAOATHOCPRUKG-UHFFFAOYSA-N 0.000 claims description 3
- XSTDIWNKASNIET-UHFFFAOYSA-N 6-methoxy-2-phenyl-3,4-dihydro-2h-naphthalen-1-one Chemical compound C1CC2=CC(OC)=CC=C2C(=O)C1C1=CC=CC=C1 XSTDIWNKASNIET-UHFFFAOYSA-N 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 3
- 150000003254 radicals Chemical class 0.000 claims description 3
- 241000251730 Chondrichthyes Species 0.000 claims description 2
- WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical compound F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 claims description 2
- 150000001340 alkali metals Chemical group 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- DVIUIRUQKVUCNG-UHFFFAOYSA-N 2-phenyl-3,4-dihydro-2h-naphthalen-1-one Chemical compound C1CC2=CC=CC=C2C(=O)C1C1=CC=CC=C1 DVIUIRUQKVUCNG-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- 239000004305 biphenyl Substances 0.000 claims 1
- JNWNAQZSBRFGPC-UHFFFAOYSA-M magnesium;2-(phenoxy)oxane;bromide Chemical compound [Mg+2].[Br-].O1CCCCC1OC1=CC=[C-]C=C1 JNWNAQZSBRFGPC-UHFFFAOYSA-M 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 33
- 239000000243 solution Substances 0.000 description 26
- 239000000203 mixture Substances 0.000 description 25
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 22
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 18
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 18
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- 239000002904 solvent Substances 0.000 description 14
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 10
- XHLHPRDBBAGVEG-UHFFFAOYSA-N 1-tetralone Chemical compound C1=CC=C2C(=O)CCCC2=C1 XHLHPRDBBAGVEG-UHFFFAOYSA-N 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 239000011541 reaction mixture Substances 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 9
- 150000004795 grignard reagents Chemical class 0.000 description 8
- 239000012442 inert solvent Substances 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 150000002825 nitriles Chemical class 0.000 description 8
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 7
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 7
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 7
- 238000002844 melting Methods 0.000 description 7
- 230000008018 melting Effects 0.000 description 7
- 239000012044 organic layer Substances 0.000 description 7
- 238000001953 recrystallisation Methods 0.000 description 7
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 6
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 6
- 239000007818 Grignard reagent Substances 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 description 5
- 150000002576 ketones Chemical class 0.000 description 5
- 235000010755 mineral Nutrition 0.000 description 5
- 239000011707 mineral Substances 0.000 description 5
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 150000003935 benzaldehydes Chemical class 0.000 description 4
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N methyl pentane Natural products CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 239000000575 pesticide Substances 0.000 description 4
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- HUHXLHLWASNVDB-UHFFFAOYSA-N 2-(oxan-2-yloxy)oxane Chemical compound O1CCCCC1OC1OCCCC1 HUHXLHLWASNVDB-UHFFFAOYSA-N 0.000 description 3
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzenecarboxaldehyde Natural products O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 235000005513 chalcones Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 125000001033 ether group Chemical group 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 238000002329 infrared spectrum Methods 0.000 description 3
- 150000004715 keto acids Chemical class 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 150000002989 phenols Chemical class 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 2
- PANZFQYXPMCHFD-UHFFFAOYSA-N 2,3-diphenyl-1h-indene Chemical class C12=CC=CC=C2CC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 PANZFQYXPMCHFD-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- WMPPDTMATNBGJN-UHFFFAOYSA-N 2-phenylethylbromide Chemical class BrCCC1=CC=CC=C1 WMPPDTMATNBGJN-UHFFFAOYSA-N 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- OSDWBNJEKMUWAV-UHFFFAOYSA-N Allyl chloride Chemical compound ClCC=C OSDWBNJEKMUWAV-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- 239000002841 Lewis acid Substances 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical group C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- ZDVDCDLBOLSVGM-UHFFFAOYSA-N [chloro(phenyl)methyl]benzene Chemical compound C=1C=CC=CC=1C(Cl)C1=CC=CC=C1 ZDVDCDLBOLSVGM-UHFFFAOYSA-N 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 2
- 239000000538 analytical sample Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 150000008366 benzophenones Chemical class 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000020335 dealkylation Effects 0.000 description 2
- 238000006900 dealkylation reaction Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000035558 fertility Effects 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical group [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000007517 lewis acids Chemical class 0.000 description 2
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- 229940075930 picrate Drugs 0.000 description 2
- OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 description 2
- 125000003386 piperidinyl group Chemical group 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- JIRHAGAOHOYLNO-UHFFFAOYSA-N (3-cyclopentyloxy-4-methoxyphenyl)methanol Chemical compound COC1=CC=C(CO)C=C1OC1CCCC1 JIRHAGAOHOYLNO-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- YBUUDNGHUKBXSG-ZHACJKMWSA-N (e)-1-(3-methoxyphenyl)-3-phenylprop-2-en-1-one Chemical compound COC1=CC=CC(C(=O)\C=C\C=2C=CC=CC=2)=C1 YBUUDNGHUKBXSG-ZHACJKMWSA-N 0.000 description 1
- FMMUNDXXVADKHS-UHFFFAOYSA-N 1,3-dimethylpiperazine Chemical group CC1CN(C)CCN1 FMMUNDXXVADKHS-UHFFFAOYSA-N 0.000 description 1
- ZNGWEEUXTBNKFR-UHFFFAOYSA-N 1,4-oxazepane Chemical group C1CNCCOC1 ZNGWEEUXTBNKFR-UHFFFAOYSA-N 0.000 description 1
- BAYUSCHCCGXLAY-UHFFFAOYSA-N 1-(3-methoxyphenyl)ethanone Chemical compound COC1=CC=CC(C(C)=O)=C1 BAYUSCHCCGXLAY-UHFFFAOYSA-N 0.000 description 1
- JVHBOFRQAFUFCE-UHFFFAOYSA-N 1-(azepan-1-yl)-1,4-diazepane Chemical compound C1CCCN(CC1)N1CCCNCC1 JVHBOFRQAFUFCE-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- MPPPKRYCTPRNTB-UHFFFAOYSA-N 1-bromobutane Chemical compound CCCCBr MPPPKRYCTPRNTB-UHFFFAOYSA-N 0.000 description 1
- VMKOFRJSULQZRM-UHFFFAOYSA-N 1-bromooctane Chemical compound CCCCCCCCBr VMKOFRJSULQZRM-UHFFFAOYSA-N 0.000 description 1
- VCZGSZNDVUPZAL-UHFFFAOYSA-N 2-(3-methoxyphenyl)-4-oxobutanenitrile Chemical compound C(#N)C(CC=O)C1=CC(=CC=C1)OC VCZGSZNDVUPZAL-UHFFFAOYSA-N 0.000 description 1
- MXDQGXMBJCGRCB-UHFFFAOYSA-N 2-(4-bromophenoxy)oxane Chemical compound C1=CC(Br)=CC=C1OC1OCCCC1 MXDQGXMBJCGRCB-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- NNWUEBIEOFQMSS-UHFFFAOYSA-N 2-Methylpiperidine Chemical compound CC1CCCCN1 NNWUEBIEOFQMSS-UHFFFAOYSA-N 0.000 description 1
- NAMYKGVDVNBCFQ-UHFFFAOYSA-N 2-bromopropane Chemical compound CC(C)Br NAMYKGVDVNBCFQ-UHFFFAOYSA-N 0.000 description 1
- YMDNODNLFSHHCV-UHFFFAOYSA-N 2-chloro-n,n-diethylethanamine Chemical compound CCN(CC)CCCl YMDNODNLFSHHCV-UHFFFAOYSA-N 0.000 description 1
- BKOOMYPCSUNDGP-UHFFFAOYSA-N 2-methylbut-2-ene Chemical group CC=C(C)C BKOOMYPCSUNDGP-UHFFFAOYSA-N 0.000 description 1
- JOMNTHCQHJPVAZ-UHFFFAOYSA-N 2-methylpiperazine Chemical compound CC1CNCCN1 JOMNTHCQHJPVAZ-UHFFFAOYSA-N 0.000 description 1
- RGHPCLZJAFCTIK-UHFFFAOYSA-N 2-methylpyrrolidine Chemical compound CC1CCCN1 RGHPCLZJAFCTIK-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- QFNABHBYVSJWLO-UHFFFAOYSA-N 3,4,4a,5-tetrahydro-2h-naphthalen-1-one Chemical compound C1C=CC=C2C(=O)CCCC21 QFNABHBYVSJWLO-UHFFFAOYSA-N 0.000 description 1
- JEGMWWXJUXDNJN-UHFFFAOYSA-N 3-methylpiperidine Chemical compound CC1CCCNC1 JEGMWWXJUXDNJN-UHFFFAOYSA-N 0.000 description 1
- MMHUEZJAURUVAD-UHFFFAOYSA-N 4-(3-methoxyphenyl)-2-phenylbutanoic acid Chemical compound COC1=CC=CC(CCC(C(O)=O)C=2C=CC=CC=2)=C1 MMHUEZJAURUVAD-UHFFFAOYSA-N 0.000 description 1
- JHHYMMHRLMDWNT-UHFFFAOYSA-N 4-(3-methoxyphenyl)-3-oxo-2-phenylbutanoic acid Chemical compound C1(=CC=CC=C1)C(C(=O)O)C(CC1=CC(=CC=C1)OC)=O JHHYMMHRLMDWNT-UHFFFAOYSA-N 0.000 description 1
- JOOIRBYSZOBPGL-UHFFFAOYSA-N 4-(3-methoxyphenyl)-4-oxo-2-phenylbutanenitrile Chemical compound COC1=CC=CC(C(=O)CC(C#N)C=2C=CC=CC=2)=C1 JOOIRBYSZOBPGL-UHFFFAOYSA-N 0.000 description 1
- AKEWACPMOFYPIH-UHFFFAOYSA-N 4-(3-methoxyphenyl)-4-oxo-2-phenylbutanoic acid Chemical compound COC1=CC=CC(C(=O)CC(C(O)=O)C=2C=CC=CC=2)=C1 AKEWACPMOFYPIH-UHFFFAOYSA-N 0.000 description 1
- GZFGOTFRPZRKDS-UHFFFAOYSA-N 4-bromophenol Chemical compound OC1=CC=C(Br)C=C1 GZFGOTFRPZRKDS-UHFFFAOYSA-N 0.000 description 1
- QOWAWWLGBCNRSP-UHFFFAOYSA-N 6-hydroxy-2-phenyl-3,4-dihydro-2h-naphthalen-1-one Chemical compound C1CC2=CC(O)=CC=C2C(=O)C1C1=CC=CC=C1 QOWAWWLGBCNRSP-UHFFFAOYSA-N 0.000 description 1
- 229910000497 Amalgam Inorganic materials 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 150000001559 benzoic acids Chemical class 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
- RCTYPNKXASFOBE-UHFFFAOYSA-M chloromercury Chemical compound [Hg]Cl RCTYPNKXASFOBE-UHFFFAOYSA-M 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 150000008050 dialkyl sulfates Chemical class 0.000 description 1
- HMOJUCUJIXEKOH-UHFFFAOYSA-N dicyanoalumanylformonitrile Chemical compound N#C[Al](C#N)C#N HMOJUCUJIXEKOH-UHFFFAOYSA-N 0.000 description 1
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 1
- 229940008406 diethyl sulfate Drugs 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 1
- VRZVPALEJCLXPR-UHFFFAOYSA-N ethyl 4-methylbenzenesulfonate Chemical compound CCOS(=O)(=O)C1=CC=C(C)C=C1 VRZVPALEJCLXPR-UHFFFAOYSA-N 0.000 description 1
- 229960003750 ethyl chloride Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 150000002440 hydroxy compounds Chemical class 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 150000002469 indenes Chemical class 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- VUQUOGPMUUJORT-UHFFFAOYSA-N methyl 4-methylbenzenesulfonate Chemical compound COS(=O)(=O)C1=CC=C(C)C=C1 VUQUOGPMUUJORT-UHFFFAOYSA-N 0.000 description 1
- REUSRIYEEARJHG-UHFFFAOYSA-N n,n-diethyl-2-[4-(5-methoxy-2-phenyl-3h-inden-1-yl)phenoxy]ethanamine;hydrochloride Chemical compound Cl.C1=CC(OCCN(CC)CC)=CC=C1C1=C(C=2C=CC=CC=2)CC2=CC(OC)=CC=C12 REUSRIYEEARJHG-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- SNMVRZFUUCLYTO-UHFFFAOYSA-N n-propyl chloride Chemical compound CCCCl SNMVRZFUUCLYTO-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- SUSQOBVLVYHIEX-UHFFFAOYSA-N phenylacetonitrile Chemical class N#CCC1=CC=CC=C1 SUSQOBVLVYHIEX-UHFFFAOYSA-N 0.000 description 1
- 125000004344 phenylpropyl group Chemical group 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 229940066768 systemic antihistamines aminoalkyl ethers Drugs 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- PUGUQINMNYINPK-UHFFFAOYSA-N tert-butyl 4-(2-chloroacetyl)piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCN(C(=O)CCl)CC1 PUGUQINMNYINPK-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-M toluene-4-sulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-M 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/11—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms
- C07C37/20—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms using aldehydes or ketones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
- C07C41/30—Preparation of ethers by reactions not forming ether-oxygen bonds by increasing the number of carbon atoms, e.g. by oligomerisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/657—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
- C07C49/665—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system
- C07C49/67—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system having two rings, e.g. tetralones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
- C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
- C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
- C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
- C07C57/60—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings having unsaturation outside the rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/88—Unsaturated compounds containing keto groups containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
U93323U93323
DR. JU^ DiPL-C'FM. WALTER BEILDR. JU ^ DiPL-C'FM. WALTER BEIL
·. · ;-J WOLFF·. ·; -J WOLFF
1 ■ S3= Dez. 1968 1 ■ S3 = December 1968
, v,^; U- HÖCHST, v, ^; U- HIGHEST
Unsere Nr. 10 823Our no. 10 823
The Upjohn Company Kalamazoo (Mich., V.St,A.)The Upjohn Company Kalamazoo (Mich., V.St, A.)
1,2-Diphenyl-3,4-dihydronaphthaline und ihre Säureanlagerungssalze sowie quaternären Ammoniumverbindungen1,2-Diphenyl-3,4-dihydronaphthalenes and their acid addition salts as well as quaternary ammonium compounds
Gegenstand der Erfindung sind 1,2-Diphenyl-3,4-dihydronaphthaline der allgemeinen FormelThe invention relates to 1,2-diphenyl-3,4-dihydronaphthalenes the general formula
.OM.OM
in der M Wasserstoff oder ein Alkalimetall, R^ und Rp einen niedrigen Alkyl-, niedrigen Alkenyl, niedrigen Alkoxy- oder niedrigen Alkenyloxyrest, die Hydroxylgruppe, Fluor oder Chlor, der' i'rifluormetfoyl-, einen niedrigen Alkylmercaptorest oder ie Gruppe -0-A-iJ^3 bedeuten, wobei A ein Allcylenrest mit '<d-6 Kohlenstoffatomen ist, R, und R. einzeln niedrige Alkylreüte oder zusammen mit dem Stickstoffatom einen 5- bisin which M is hydrogen or an alkali metal, R ^ and Rp a lower alkyl, lower alkenyl, lower alkoxy or lower alkenyloxy radical, the hydroxyl group, fluorine or chlorine, the 'i'rifluormetfoyl-, a lower alkyl mercapto radical or ie group -0- A-iJ ^ 3, where A is an Allcylenrest with '<d-6 carbon atoms, R, and R. individually low alkyl purity or together with the nitrogen atom a 5- to
909829/1572 bad original909829/1572 bad original
7-gliedrigen gesättigten heterocyclischen Rest bilden und x und y die Zahlen 0,1 oder 2 darstellen, sowie pharmakologisch geeignete Säureanlagerungssalze und quaternäre Ammoniumderivate der Verbindungen, in denen M Wasserstoff und7-membered saturated heterocyclic radical form and x and y represent the numbers 0.1 or 2, as well as pharmacologically suitable acid addition salts and quaternary ammonium derivatives of compounds in which M is hydrogen and
mindestens einer der Reste R^ und Rp die Gruppe -0-Α~Ν(^3 bedeutet.at least one of the radicals R ^ and Rp the group -0-Α ~ Ν (^ 3 means.
Das erfindungsgemässe Verfahren zur Herstellung dieser Verbindungen besteht darin, dass man in an sich bekann-fcer Weise ein 1,2,3»4-Tetrahydro-2-phenyl-1-naphthalinon der allgemeinen The inventive method for preparing these compounds is that they be beka nn -fcer, a 1,2,3 '4-tetrahydro-2-phenyl-1-naphthalenone in a general
in der ^c ^1^ ^6 einen niedrigen Alkyl-, niedrigen Alkenyl-, niedrigen Alkoxy-, niedrigen Alkenyloxy- oder den 2-Tetrahydropyranyloxyrest, Fluor oder Chlor, den Trifluormethylrest, einen niedrigen Alkylmercaptorest oder die Gruppein the ^ c ^ 1 ^ ^ 6 a lower alkyl, lower alkenyl, lower alkoxy, lower alkenyloxy or the 2-tetrahydropyranyloxy radical, fluorine or chlorine, the trifluoromethyl radical, a lower alkyl mercapto radical or the group
- 0 - A - N ■* bedeuten, in Gegenwart eines inerten orga- R4 - 0 - A - N ■ * mean in the presence of an inert orga- R 4
Lösungsmittels mit einem Grignard-ßeagenz der allgemeinen FormelSolvent with a Grignard reagent of the general formula
IIIIII
Mg HaiMg shark
BAD OPlGINALBATHROOM OPlGINAL
9/15729/1572
umsetzt, in der Hai ein Halogenatom darstellt, gegebenenfalls
gebildetes Carbinol dehydratisiert, die erhaltene
Verbindung der allgemeinen Formelconverts, in which Hai represents a halogen atom, optionally formed carbinol is dehydrated, the obtained
Compound of the general formula
IVIV
sauer hydrolysiert und gegebenenfalls anschliessend die
erhaltenen Verbindungen in Alkalimetallsalze, Säureanlagerungssalze oder quaternäre Ammoniumverbindungen überführt.acid hydrolyzed and, if necessary, then the
The compounds obtained are converted into alkali metal salts, acid addition salts or quaternary ammonium compounds.
Die erfindungagemäss angewandten Massnahmen sind als solche
bekannt. So ist z.B. die Grignardierung eines cyclischen
Ketone in der US-Patentschrift 2 566 357 beschrieben.The measures used according to the invention are known as such. For example, Grignardation is a cyclic one
Ketones are described in U.S. Patent 2,566,357.
Unter dem Ausdruck "niedrige Alkylreste" sind Alkylreste
mit 1 bis 8 Kohlenstoffatomen zu versetehen, wie der Methyl-, Äthyl-, i'rcpyl-, Butyl-, Amyl-, Hexyl-, Heptyl-, Octylrest
und deren Isomere; unter dem Ausdruck "niedrige Alkylenreste" Alkenylreste mit 2 bis 8 Kohlenstoffatomen, wie der Vinyl-,
Allyl-, Butenyl-, Pentenyl-, Hexenyl-, Heptenyl-, Octenylrest und deren Isomere; unter dem Ausdruck "niedrige Alkoxy_
reste" Alkoxyreste mit 1 bis 8 Kohlenstoffatomen, wie der
Methoxy-, Athoxy-, rropoxy-, Butoxy_ Amyloxy-, Hexyloxy-,
Heptyloxy-, Cctyloxyrest und deren i-somere; unter dem Ausdruck
"niedrige Alkenyloxyrest" Alkenyloxyres-te mit 2. "bis
S Kohlenstoffatomen, wie der Vinyloxv- Allyloxy-, Butenj'l-By the term "lower alkyl" is meant alkyl
to be provided with 1 to 8 carbon atoms, such as the methyl, ethyl, i'rcpyl, butyl, amyl, hexyl, heptyl, octyl radical and their isomers; the expression "lower alkylene radicals" means alkenyl radicals having 2 to 8 carbon atoms, such as the vinyl, allyl, butenyl, pentenyl, hexenyl, heptenyl, octenyl radical and their isomers; the expression "lower alkoxy_ res te" alkoxy radicals having 1 to 8 carbon atoms, such as methoxy, ethoxy, rropoxy, butoxy_ amyloxy, hexyloxy, heptyloxy, cycloxy radical and their isomers; under the expression "lower alkenyloxy" alkenyloxy res -te with 2. "to S carbon atoms, such as the Vinyloxv- Allyloxy-, Butenj'l-
BAD ORIGINAL
909829/1572 BATH ORIGINAL
909829/1572
oxy-, Pentenyloxy-, Hexenyloxy-, Heptenyloxy-, Octenyloxyrest und deren Isomere. Der Ausdruck "niedrige Alkylmercaptoreste" bezeichnet Alkylmercaptoreste mit 1 bis 8 Kohlenstoffatomen, wie den Methylmercapto-, Äthylgiercapto-, Propylmercapto-, Butylmeroapto-, Amylmercapto-„ Hexylmercapto-, Heptylmercapto-, Octylmercaptorest und deren Isomere; der Ausdruck MAlkylengruppen mit 2 bis 6 Kohlenstoffatomen" den Äthylen-, Propylen-, Butylen-, Amylen-, Hexylenrest und deren ^somere. Der aus R, und R. und dem benachbarten Stickstoffatom gebildete 5- bis 7-gliedrige gesättigte heterocyclische Ring kann der Pyrrolidinring, ein durch niedrige Alkylgruppen substituierter Pyrrolidinring, wie der 2-Methylpyrrolidin-, 2,2-Dimethylpyrrolidin- oder 3-Methylpyrrolidinring; der Piperazinring, ein durch niedrige Alkylgruppen substituierter Piperazinring, wie der 2-Methylpiperazin-, 4-Methylpiperazin- oder 2,4-Dimethylpiperazinring; der Piperidinring, ein durch niedrige Alkylgruppen substituierter Piperidinring, wie der 2-Methylpiperidin-, 3-Methylpiperidin- oder 4»4—Dimethylpiperidinring; der Morpholin-, Hexamethylenimino-, Homopiperazin- oder Homomorpholinring sein·oxy, pentenyloxy, hexenyloxy, heptenyloxy, octenyloxy radicals and their isomers. The term "lower alkyl mercapto radicals" denotes alkyl mercapto radicals with 1 to 8 carbon atoms, such as the methyl mercapto, ethylgiercapto, propyl mercapto, butyl mercapto, amyl mercapto, hexyl mercapto, heptyl mercapto, octyl mercapto radical and their isomers; the term M alkylene groups with 2 to 6 carbon atoms "the ethylene, propylene, butylene, amylene, hexylene radical and their ^ somers. The 5- to 7-membered saturated heterocyclic ring formed from R, and R. and the adjacent nitrogen atom may be the pyrrolidine ring, substituted by lower alkyl groups pyrrolidine ring, such as the 2-methylpyrrolidin, 2,2-Dimethylpyrrolidin- or 3 Methylpyrrolidinring; the piperazine ring, by a lower alkyl group substituted Pipera in-ring such as the 2-methylpiperazine, 4- Methylpiperazine or 2,4-dimethylpiperazine ring; the piperidine ring, a piperidine ring substituted by lower alkyl groups, such as the 2-methylpiperidine, 3-methylpiperidine or 4 »4-dimethylpiperidine ring; the morpholine, hexamethyleneimino, homopiperazine or homomorpholine ring
Die erfindungsgemässen Verbindungen können als freie Phenole oder in Form ihrer Alkalimetallsalze, z.B. als Natrium-, Kalium- oder Lithiumsalze vorliegen, ferner als Säureanlagerunge- oder quaternäre Ammoniumsalze, wenn M Wasserstoff ist und R1 und/oder R2 die ^ruppe -O-A-N^3 · darstellen· Geeignete Säureanlagerungssalze werden mit pharmakologisch annehmbaren Säuren, wie Schwefelsäure, Salzsäure, Salpetersäure, Phosphorsäure, Milchsäure, Benzoesäure, Methansulfonsäure, p-Toluolsulfonsäure, Salicylsäure, Essigsäure, Propionsäure, Maleinsäure, Äpfelsäure, Weinsäure, Zitronensäure, Cyclohexylsulfaminsäure, Bernsteinsäure, Nicotinsäure und Ascorbinsäure erhalten. Die quaternären Ammonium-The compounds according to the invention can be present as free phenols or in the form of their alkali metal salts, for example as sodium, potassium or lithium salts, and also as acid addition or quaternary ammonium salts when M is hydrogen and R 1 and / or R 2 are the group -OAN ^ 3 · represent · Suitable acid addition salts are mixed with pharmacologically acceptable acids such as sulfuric acid, hydrochloric acid, nitric acid, phosphoric acid, lactic acid, benzoic acid, methanesulfonic acid, p-toluenesulfonic acid, salicylic acid, acetic acid, propionic acid, maleic acid, malic acid, tartaric acid, citric acid, cyclohexylic acid and ascorbic acid. The quaternary ammonium
909829/1572 BAD original909829/1572 BAD original
salze erhält man durch Umsetzung der freien Phenole mit Quaternierungsmitteln, wie niedrigen Alky!halogeniden, bis-(niedrig Alkyl)-sulfaten, Aralky!halogeniden und niedrigen Alkylarylsulfonaten. Unter dem Ausdruck "Aralkyl" sind Aralkylgruppen mit 7 bis 13 Kohlenstoffatomen zu versetehen, wie der Benzyl-, Phenäthyl-, Phenylpropyl- und Benzhydrylreste Der Ausdruck "niedrige Alkylarylsulfonate" bezeichnet Ester aus niedrigen Alkanolen und Arylsulfonsäuren, wie Benzolsulfonsäure, Toluolsulfonsäure, Xylolsulfonsäure und ähnliche Säuren, Beispiele für quaternäre Salze sind das Methobromid, Methojodid, Ithobromid, Propylchlorid, Butylbromid, Octylbromid, Methylmethosulfat, Äthyläthosulfat, Allylchlorid, Allylbromid, Benzylbromid, Benzhydrylchlorid, Methyl~p-toluolsulfonat und Äthyl-p-toluolsulfonat.Salts are obtained by reacting the free phenols with quaternizing agents such as lower alkyl halides, bis (lower alkyl) sulfates, aralky! halides and lower Alkyl aryl sulfonates. Under the term "aralkyl" are To provide aralkyl groups with 7 to 13 carbon atoms, such as the benzyl, phenethyl, phenylpropyl and benzhydryl radicals The term "lower alkyl aryl sulfonates" denotes Esters of lower alkanols and arylsulfonic acids, such as benzenesulfonic acid, toluenesulfonic acid, xylene sulfonic acid and similar acids, examples of quaternary salts are methobromide, methojodide, ithobromide, propyl chloride, Butyl bromide, octyl bromide, methyl methosulphate, ethyl ethosulphate, Allyl chloride, allyl bromide, benzyl bromide, benzhydryl chloride, methyl ~ p-toluene sulphonate and ethyl p-toluene sulphonate.
Die erfindungsgemässen Verbindungen setzen die Fruchtbarkeit herab und sind in dieser Hinsicht den in "Society of Chemical Industry", S. 2098/99, 1961 beschriebenen 2,3-Diphenylindenen eindeutig überlegen. Die Untersuchung des erfindungsgemässen 1-(p-Hydroxylphenyl)-2-phenyl-6-methoxy-3,4-dihydronaphthalins nach der in "Proceedings of the Society for Experimental Biology and Medicine" S, 163-166, erläutern Methode ergab eine MDE50 von 0,025 mg/kg/Tg. Die MED50 des 2-Phenyl-3-(p-diäthylaminoäthoxyphenyl)-6-methoxy-inden-hydrochlorids, d.h. des wirksamsten der bekannten 2,3-Diphenyl-indenderivate betrug dagegen °»5 mg/ kg/Tg. Die erfindungsgemässen Verbindungen sind also 20mal so wirksam wie die bekannten Indene,Wie diese stellen sie keine Steroide dar und weisen damit auch nicht die unerwünschten Nebenwirkungen dieser ^erbindungen auf.The compounds according to the invention reduce fertility and in this respect are clearly superior to the 2,3-diphenylindenes described in "Society of Chemical Industry", pp. 2098/99, 1961. The investigation of the 1- (p-hydroxylphenyl) -2-phenyl-6-methoxy-3,4-dihydronaphthalene according to the method explained in "Proceedings of the Society for Experimental Biology and Medicine" S, 163-166 resulted in an MDE 50 of 0.025 mg / kg / day. The MED 50 of 2-phenyl-3- (p-diethylaminoethoxyphenyl) -6-methoxy-indene hydrochloride, ie the most effective of the known 2,3-diphenyl-indene derivatives, on the other hand, was ± 5 mg / kg / day. The compounds according to the invention are therefore 20 times as effective as the known indenes. Like these, they are not steroids and therefore do not have the undesirable side effects of these compounds.
Die Verbindungen gemäss der Erfindung besitzen ferner entzündungshemmende, antimikrobielle und das Zentralnervensystem stimulierende Wirkung,The compounds according to the invention also have anti-inflammatory, antimicrobial and central nervous system stimulating effects,
mm Q mm mm Q mm
Auf Grund ihrer entzündungshemmenden Wirkung eignen sie sich zur topischen Anwendung bei Entzündungen und Verbrennungen, ferner zur atopischen Behandlung von Dermatitis und Kontaktdermatitis·Due to their anti-inflammatory effect, they are suitable for topical use in cases of inflammation and burns, also for atopic treatment of dermatitis and contact dermatitis
Für die Verabreichung an Menschen und Säugetiere können die erfindungsgemässen Verbindungen mit festen pharmazeutischen Trägern zu Tabletten, Pulvern, Kapseln und ähnlichen Dosierungsformen verarbeitet werden. Mit geeigneten Lösungs- oder Dispergiermitteln ergeben sie flüssige orale und parenterale Verabreichungsformen.For administration to humans and mammals can the compounds according to the invention with solid pharmaceutical carriers to form tablets, powders, capsules and the like Dosage forms are processed. With suitable solvents or dispersants, they result in liquid oral fluids and parenteral administration forms.
Die Verbindungen gemäss der Erfindung stellen ferner wertvolle Ausgangsstoffe für weitere Umsetzungen dar. So ergeben die freien Phenole bei ihrer Umsetzung mit tertiären Aminoalky!halogeniden der Formel Hal-A-N/ P3 in GegenwartThe compounds according to the invention are also valuable starting materials for further reactions. For example, the free phenols, when reacted with tertiary aminoalkyl halides of the formula Hal-AN / P 3 in the presence
^4 einer Base, wie Natriumhydroxyd, Kaliumhydroxyd oder Natriummethylat Aminoalkyläther, die ebenfalls die Fruchtbarkeit herabsetzen (s, die Veröffentlichungen von Lednicer und Mitarbeitern, "Chemistry and Industry", 1961, S, 2098; ibid. 1963, S. 408).^ 4 a base such as sodium hydroxide, potassium hydroxide or sodium methylate Aminoalkyl ethers, which also reduce fertility (see the publications by Lednicer et al., Chemistry and Industry, 1961, pp. 2098; ibid. 1963, p. 408).
Bei der erfindungsgemässen Umsetzung wird das Keton (il) unter üblichen Grignardierungsbedingungen, d.h. unter wasserfreien Bedingungen, vorzugsweise in Gegenwart eines inerten Lösungsmittels, wie Dibutyläther, Diisopropyläther oder Tetrahydrofuran mit dem Grignard-Reagenz (III) umgesetzt. Als lösungsmittel wird tetrahydrofuran bevorzugt. Die Umsetzung kann bei Temperaturen zwischen etwa O0C und dem Siedepunkt des verwendeten Lösungsmittels erfolgen; vorzugsweise arbeitet man bei erhöhten Temperaturen, z.B. bei oder in der Nähe des Siedepunktes deß Reaktionsgemisches.In the inventive reaction that is carried out under anhydrous conditions, preferably in the presence of an inert solvent, such as dibutyl ether, diisopropyl ether or tetrahydrofuran, with the Grignard reagent is d a s ketone (il) under conventional Grignardierungsbedingungen reacted (III). Tetrahydrofuran is the preferred solvent. The reaction can take place at temperatures between about 0 ° C. and the boiling point of the solvent used; it is preferred to work at elevated temperatures, for example at or near the boiling point of the reaction mixture.
Die Reaktionszeit kann je nach der angewandten Reaktionstemperatur stark schwanken. Arbeitet man bei erhöhten Tem-The reaction time can depend on the reaction temperature used fluctuate greatly. If you work at elevated temperatures
6 0Ö829/1S76 0Ö829 / 1S7
ff · «
11 · · ·ff · «
1 1 · · ·
U93323U93323
peraturen, z.B. beim Siedepunkt des Reaktionsgemischs, bo sind für eine vollständige Umsetzung im allgemeinen mehrere Stunden erforderlich.temperatures, e.g. at the boiling point of the reaction mixture, bo are generally required several hours for a complete conversion.
Die gewünschte Verbindung (i) kann zunächst als Tetrahydropyranyläther isoliert und aus ihr anschliessend die Äthergruppe entfernt werden· Es ist aber auch möglich, die Äthergruppe bereits während der Isolierung des Reaktionsproduktes abzuspalten. Die Entfernung der Äthergruppe lässt sich leicht durch Hydrolyse mit Mineralsäuren erreichen und wird vorzugsweise während der Aufarbeitung des xroduktes vorgenommen.The desired compound (i) can first be isolated as tetrahydropyranyl ether and the ether group can then be removed from it. However, it is also possible to split off the ether group during the isolation of the reaction product. Removal of the ether group is easily by hydrolysis with mineral acids achieve and is preferably carried out during the working up of the x roduktes.
Z.B. kann man das erhaltene Reaktionsgemisch durch Zugabe von Wasser oder Ammoniumohloridlösung zersetzen, worauf die organische Schicht abgetrennt und das Lösungsmittel entfernt wird. Der Rückstand aus dem ^etrahydropyranyläther (IV) wird dann hydrolysiert, vorzugsweise indem man eine Lösung des Äthers in einem geeigneten organischen inerten Lösungsmittel, wie Aceton, Methanol, Äthanol oder in Gemischen dieser Lösungsmittel mit Wasser und einer wässrigen Mineralsäure, wie Salzsäure oder Bromwasserstoffsäure, versetzt und stehen lässt.For example, the reaction mixture obtained can be decomposed by adding water or ammonium chloride solution, whereupon separating the organic layer and removing the solvent. The residue from the ^ etrahydropyranyläther (IV) is then hydrolyzed, preferably by adding a solution of the ether in a suitable organic inert Solvents such as acetone, methanol, ethanol or mixtures of these solvents with water and an aqueous one Mineral acid, such as hydrochloric acid or hydrobromic acid, relocated and let stand.
Die gewünschte Verbindung (i) wird aus dem Hydrolysegemisch in bekannter ^eise isoliert, z.B. durch Lösungsmittelextraktion, und dann, falls gevrtinscht, in üblicher Weise gereinigt, z.B. durch Chromatographieren oder Umkristallisieren.The desired compound (i) is obtained from the hydrolysis mixture isolated in a known manner, e.g. by solvent extraction, and then, if necessary, purified in the usual way, e.g. by chromatography or recrystallization.
Die Verbindung (I) kann durch merkliche Mengen des entsprechenden Carbinols der allgemeinen FormelThe compound (I) can by appreciable amounts of the corresponding Carbinols of the general formula
SAD OWGfNAL 909829/ 1 572SAD OWGfNAL 909829/1 572
verunreinigt· sein· Erhält man ein solches Gemisch aus der erwünschten Verbindung (I) und dem entsprechenden Carbinol (VI), so kann man dieses in an sich bekannter Weise dehydratisieren, um so ausschliesslich die Verbindung (I) zu erhalten. Die Wasserabspaltung kann in den meisten Fällen durch Erhitzen des Carbinols in einem Lösungsmittel, wie Benzol oder Toluol, Xylol, das mit Wasser ein azeotrope8 Gemisch bildet, in Gegenwart von Spuren einer starken Säure, wie Salzsäure, Schwefelsäure oder p-Toluolsulfonsäure erreicht werden. Das bei der Wasserabspaltung entstehende Wasser wird azeotrop entfernt. Man erhält eine Lösung der Verbindung (I), aus der diese durch Abdampfen des Lösungsmittels oder in anderer bekannter ^eise erhalten werden kann· Manchmal erfordert die wasserabspaltung aus dem Carbinol (V) schärfere Bedingungen, z.B. das Erhitzen auf eine Temperatur, die beim oder nahe beim Schmelzpunkt der Verbindung liegt, vorzugsweise in Gegenwart eines inerten Gases, bis die WaS8erabspaltung vollständig ist.If such a mixture is obtained from the desired compound (I) and the corresponding carbinol (VI), this can be dehydrated in a manner known per se in order to obtain the compound (I) exclusively. The elimination of water can, in most cases by heating the carbinol in a solvent such as benzene or toluene, xylene, forming trope8 mixture with water an a zeo, in the presence of traces of a strong acid such as hydrochloric acid, sulfuric acid or p-toluenesulfonic acid can be achieved . The water formed in the sserabspaltung W a is removed azeotropically. A solution of the compound (I) from which it may be obtained by evaporation of the solvent or in other known ^ else obtained · sometimes requires the w asserabspaltung from the carbinol (V) severe conditions such as heating at a temperature in the or is close to the melting point of the compound, preferably in the presence of an inert gas, until the W aS8e cleavage is complete.
Wenn R.. und/oder R2 im Ausgangsketon (II) freie Hydroxyi_ gruppen sind, müssen sie vor der Grignardierung durch eine Gruppe geschützt werden, die anschliessend unter Bildung der Verbindung (I) mit freier Hydroxylgruppe oder freien Hydroxylgruppen entfernt werden kann. Besonders geeignet ist die Umwandlung der freien Hydroxyverbindung in den ent-.sprechenden ^etrahydropyranyläther. Biese Umwandlung kannIf R .. and / or R 2 in the starting ketone (II) are free hydroxyl groups, they must be protected from Grignardation by a group which can then be removed to form the compound (I) with free hydroxyl group or free hydroxyl groups. The conversion of the free hydroxy compound into the corresponding ethrahydropyranyl ether is particularly suitable. This transformation can
909829/1572909829/1572
U93323U93323
dadurch vorgenommen werden, dass man das freie Hydroxylgruppen aufweisende Keton in Gegenwart einer Spur p-Toluolsulfonsäure oder einer Mineralsäure, wie Salzsäure oder bromwasserstoff säure mit 2,3-Dihydropyran behandelt. Die Tetrahydropyranylgruppen werden nach Vornahme der erfindungsgemässen Umsetzung zusammen mit den aus der Grignardverbindung (ill) stammenden Tetrahydropyramylgruppen entfernt.be made by the fact that the ketone having free hydroxyl groups in the presence of a trace of p-toluenesulfonic acid or a mineral acid such as hydrochloric acid or hydrobromic acid treated with 2,3-dihydropyran. The tetrahydropyranyl groups after the implementation according to the invention has been carried out together with those from the Grignard compound (ill) derived tetrahydropyramyl groups removed.
Die Grignard-Reagenzien (III) erhält man in an sich bekannter V/eise durch Umsetzung von Magnesium in einem wasserfreien inerten Lösungsmittel, wie Dibutyläther, Diisopropyläther oder Tetrahydrofuran mit dem Tetrahydropyranyläther des entsprechenden Halogenphenols.The Grignard reagents (III) are obtained in a manner known per se V / eise by reacting magnesium in an anhydrous inert solvent such as dibutyl ether or diisopropyl ether or tetrahydrofuran with the tetrahydropyranyl ether of the corresponding halophenol.
Die Ausgangsietone der Formel (il) können mit Ausnahme von solchen, in denen Rr- und/oder Rr einen AlkenyloxyrestWith the exception of those in which Rr and / or Rr is an alkenyloxy radical
si
oder die Gruppe -0-A-Nx -^ bedeuten, nach folgendem Reaktions- si
or the group -0-AN x - ^ mean, according to the following reaction
schema erhalten werden:scheme can be obtained:
809829/167 2809829/167 2
VIIIVIII
XIIXII
Nach, dem obigen Reakt ions 8 chema wird ein entsprechend substituiertes Benzophenon (Vl) mit einem geeignet substitu- " ierten Benzaldehyd (VII) unter üblichen Bedingungen zum entsprechenden Chalkon (VIII) kondensiert, z.B. in Gegenwart einer Base, wie Natriumhydroxyd oder Kaliumhydroxyd, in einem inerten Lösungsmittel, wie einem Gemisch aus Wasser und einem niedrigen Alkanol, z.B. Methanol oder Äthanol»After the above reaction 8 chema is a correspondingly substituted Benzophenone (VI) with a suitably substituted benzaldehyde (VII) under customary conditions for corresponding chalcone (VIII) condensed, e.g. in the presence of a base such as sodium hydroxide or potassium hydroxide, in an inert solvent, such as a mixture of water and a lower alkanol, e.g. methanol or ethanol »
908829/1572908829/1572
Man arbeitet gewöhnlich bei oder unterhalb Raumtemperatur und kühlt, falls erforderlich, von aus3en. Das Chalkon (VIII) wird aus dem Reaktionsgemisch isoliert und in bekannter Weise gereinigt, z.B. durch Extraktion und anschiiessende Destillation.Usually one works at or below room temperature and, if necessary, cools from outside. The Chalcone (VIII) is isolated from the reaction mixture and purified in a known manner, e.g. by extraction and subsequent Distillation.
Das so erhaltene Chalkon (VIII) wird dann durch Umsetzung mit Blausäure, z.B. durch Behandlung mit einem Alkalimetallcyanid, wie Natriumcyanid oder Kaliumcyanid in Gegenwart von Essigsäure und einem inerten Lösungsmittel, wie wässrigem Methanol oder wässrigem Äthanol (Newman, J.Am.Chem. Soc. Bd. 60, S. 2947, 1938) in das entsprechende Nitril (IX) übergeführt. Das Nitril (IX) fällt im allgemeinen als Feststoff aus und kann abfiltriert und durch Umkristallisieren gereinigt werden.The chalcone (VIII) obtained in this way is then reacted with hydrocyanic acid, e.g. by treatment with an alkali metal cyanide, such as sodium cyanide or potassium cyanide in the presence of acetic acid and an inert solvent such as aqueous Methanol or aqueous ethanol (Newman, J. Am. Chem. Soc. Vol. 60, p. 2947, 1938) into the corresponding nitrile (IX) convicted. The nitrile (IX) generally precipitates as a solid and can be filtered off and recrystallized getting cleaned.
Das so erhaltene Nitril (IX) wird dann in üblicher weise zur Ketosäure (X) hydrolysiert, z.B. durch Erhitzen unter Rückfluss in Gegenwart einer wässrigen Mineralsäure, wie Schwefelsäure, bis die Hydrolyyse im wesentlichen vollständig ist. Die gewünschte Säure (X) scheidet sich im allgemeinen als Peststoff aus und kann abfiltriert und durch Umkristallisieren oder andere ^assnahmen, z.B. durch Umwandlung in ein Alkalimetallsalz und anschliessendes Ansäurn unter Regenerierung der freien Säure, gereinigt werden.The nitrile thus obtained (IX) is then hydrolyzed in the usual else w to keto acid (X), for example, until the Hydrolyyse substantially completely by heating under reflux in the presence of an aqueous mineral acid such as sulfuric acid. The desired acid (X) is generally separated out as a pesticide and can be filtered off and purified by recrystallization or other measures, for example by conversion into an alkali metal salt and subsequent acidification with regeneration of the free acid.
Die so erhaltene Ketosäure (X) wird dann zur Bildung der Säure (XI) reduziert. Die Reduktion kann in beliebiger Weise erfolgen, besonders geeignet als Reduktionsmittel ist amalgamiertes Zink. Bei Behandlung der Ketosäure (X) mit amalgamiertem Zink in Gegenwart einer Mineralsäure erhält man die gewünschte Säure (XI) in hervorragender Ausbeute. Die Säure (XI) kann aus dem Reaktionsgemisch in üblicher heise isoliert werden, z.B. durch AbdekantierenThe keto acid (X) thus obtained is then reduced to form the acid (XI). The reduction can be carried out in any way; amalgamated zinc is particularly suitable as a reducing agent. For the treatment of the keto acid (X) with zinc amalgam in the presence of a mineral acid ma n receives the desired acid (XI) in excellent yield. The acid (XI) may be made of the reaction mixture in a conventional h else be isolated, for example by decanting
; 909829/1572 ; 909829/1572
des flüssigen Reaktionsgemische,- Lösungsmittelextraktion der abdekantierten Flüssigkeit und Entfernung des Lösungsmittels, Die so erhaltene Säure ist im allgemeinen für die Weiterverarbeitung genügend rein. Falls gewünscht, kann man sie in an sich bekannter Weise reinigen, z.B. durch Destillation, Umkristallisation oder Umwandlung in ein Alkalimetallsalz und anschliessendes Ansäuern unter Bildung der freien Säure.of the liquid reaction mixtures, - solvent extraction the decanted liquid and removal of the solvent, The acid obtained in this way is generally sufficiently pure for further processing. If desired, can they are purified in a manner known per se, e.g. by distillation, recrystallization or conversion into a Alkali metal salt and subsequent acidification with formation the free acid.
In der letzten Stufe des erfindungsgemässen Verfahrens die Säure (XI) in Gegenwart einer Lewis-Säure (s. Fieser und Hershberg, loc. cit.) zum a-Tetralon (XII) eyclisiert. Als Lewis-Säure wird Fluorwasserstoff bevorzugt. Eine besonders vorteilhafte Methode zum Cyclisieren der Säure (XI) besteht darin, dass man letztere in flüssigen Fluorwasserstoff einrührt und darin den Fluorwasserstoff bei etwa 20-3O0C verdunsten lässt. Das a-Tetralon (XII) wird dann in üblicher weise aus dem Rückstand isoliert, z.B. durch Auflösen des Rückstandes in einem geeigneten Lösungsmittel, wie Äther, Waschen der erhaltenen Lösung mit einer wässrigen Lösung einer Base, wie Natriumcarbonat oder Natriumhydroxyd, und Eindampfen der gewaschenen Lösung zur Trockene. Das a-Tetralon (XII) kann, falls gewünscht, in üblicher Weise weiter gereinigt werden, z.B, durch Umkristallisieren. In the last stage of the process according to the invention, the acid (XI) is eyclized to a-tetralone (XII) in the presence of a Lewis acid (see Fieser and Hershberg, loc. Cit.). Hydrogen fluoride is preferred as the Lewis acid. A particularly advantageous method for cyclizing the acid (XI) is that the latter is stirred in liquid hydrogen fluoride and can evaporate in the hydrogen fluoride at about 20-3O 0 C. The a-tetralone (XII) is then else isolated in the usual w of the residue, for example by dissolving the residue in a suitable solvent such as ether, washing the resulting solution with an aqueous solution of a base such as sodium carbonate or sodium hydroxide, and evaporation of the washed solution to dryness. The a-tetralone (XII) can, if desired, be further purified in a customary manner, for example by recrystallization.
Die Säure (XI) kann auch durch Umwandlung in das entsprechende Säurechlorid und Behandlung des Säurechlorids mit Aluminiumchlorid oder Zinnchlorid zum Tetraion (XII) cyclysiert werden (s.Fieser und Mitarbeiter, J. Am. Chem. Soc, Bd. 60, S. 170, 1938).The acid (XI) can also be converted into the corresponding Acid chloride and treatment of the acid chloride with aluminum chloride or tin chloride to give the tetraion (XII) cyclized (see Fieser and co-workers, J. Am. Chem. Soc, Vol. 60, p. 170, 1938).
a-Tetralone, in denen R,- und/oder Rg Hydroxylgruppen sind, erhält man zweckmässig durch Entalkylierung von Verbindun-,gen der Formel (XII), in der R^ und/oder R^ Alkoxygruppena-tetralones, in which R, - and / or Rg are hydroxyl groups, is conveniently obtained by dealkylation of compounds of formula (XII), in which R ^ and / or R ^ alkoxy groups
9 0 9829/1572 bad OFlGiNAL9 0 9829/1572 bad OFlGiNAL
sind. Die Entalkylierung erfolgt in üblicher weise, z.B. durch Erhitzen mit Aluminiumchlorid oder -bromid in Gegen wart eines inerten Lösungsmittels, wie Benzol oder Xylol.are. The dealkylation is carried out in the usual w else, for example by heating with aluminum chloride or bromide in the opposite waiting an inert solvent such as benzene or xylene.
a-Tetralone (XIl), in denen Rr und/oder Rg Alkenyloxygrup pen sind, kann man durch Alkenylierung von Verbindungen erhalten, in denen Rj- und/oder Rg Hydroxylgruppen sind. Die Alkenylierung kann in bekannter weise erfolgen, z.B. durch Umsetzung der freien Hydroxylverbindung mit Alkenyl halogeniden in Gegenwart einer Base, wie Kaliumcarbonat oder Natriummethylat.α-Tetralones (XIl), in which Rr and / or Rg are alkenyloxy groups, can be obtained by alkenylation of compounds in which Rj and / or Rg are hydroxyl groups. The alkenylation can be carried out in a known else w, for example, by reacting the free hydroxyl compound with alkenyl halides in the presence of a base such as potassium carbonate or sodium methylate.
Die a-TetraloneRder Formel XII, in der Rr und/oder Rg dieThe a-tetralone R of the formula XII, in which Rr and / or Rg the
Gruppe -0—A-N^g darstellen, ka^ man durch VerätherungGroup -0 — AN ^ g can be represented by etherification
4
der freien Hydroxylverbindung mit einemiert. Aminoalkylhalogenid
erhalten. 4th
the free hydroxyl compound with one. Aminoalkyl halide obtained.
Die als Ausgangsstoffe verwendeten ^enzophenone man aus entsprechend substituierten Benzoesäuren durch Umwandlung in Säurechloride und anschliessende Umsetzung mit einer Diarylcadmiumverbindung erhalten, βτ Chemical Reviews, Bd. 40, S. 15, 1947.The enzophenones used as starting materials are obtained from appropriately substituted benzoic acids by conversion into acid chlorides and subsequent reaction with a diarylcadmium compound, Chemical Reviews, Vol. 40, p. 15, 1947.
Die Benzaldehyde (VII) sind durch Reduktion entsprechend substituierter -^enzoylchloride mit Iiithium-tri-tert.-butoxylaluminiumhydrid erhältlich, s. Brown et. al., J.Am.Chem. Soc., Bd. 80, S. 5377, 1958.The benzaldehydes (VII) are correspondingly substituted - ^ enzoylchloride by reduction with lithium tri-tert.-butoxylaluminum hydride available, see Brown et. al., J. Am. Chem. Soc., Vol. 80, pp. 5377, 1958.
Die a-Tetralone (XII) können ferner nach Newman, J. Am. Chem. Soc, Bd. 62, S. 2295, 1940 durch Umsetzung eines entsprechend substituierten Benzylcyanids der allgemeinen FormelThe α-tetralons (XII) can also be according to Newman, J. Am. Chem. Soc, Vol. 62, p. 2295, 1940 by implementing a correspondingly substituted benzyl cyanide of the general formula
909829/1572909829/1572
U93323U93323
-H--H-
CH2CNCH 2 CN
mit einem entsprechend substituierten Phenäthylbromid der allgemeinen Formelwith an appropriately substituted phenethyl bromide of the general formula
in Gegenwart von Natriumamid, Hydrolyse des erhaltenen Nitrile und Cyclysierung der gebildeten Säure wie oben beschrieben hergestellt werden.in the presence of sodium amide, hydrolysis of the nitrile obtained and cyclysation of the acid formed as above described.
Die Säureanlagerungssalze der erfindungsgemässen Verbindungen der allgemeinen Formel (i), in der M Wasserstoff und H1 und/oder Rg eine tert. Aminogruppe ist, können nach an sich bekannten Verfahren erhalten werden· Z.B. kann man die freie Base mit einer pharmakologisch annehmbaren Säure in Gegenwart eines inerten Lösungsmittels, wie Wasserj Äther, niedrigen Alkanolen, wie Methanol oder Äthanol, umsetzen.The acid addition salts of the compounds according to the invention of the general formula (i), in which M is hydrogen and H 1 and / or Rg is a tert. Amino group can be obtained by processes known per se. For example , the free base can be reacted with a pharmacologically acceptable acid in the presence of an inert solvent such as water ether, lower alkanols such as methanol or ethanol.
Die quaternären Ammoniumsalze erhält man durch Umsetzung der freien Base mit einem quaternisierenden Mittel, wie einem Alkylhalogenid, z.B. Methyljodid, ,Äthylchlorid oder Isopropylbromid, einem Alkenylhalogenid, wie Allylchlorid oder Allylbromid, einem Dialkylsulfat, wie Dimethylsulfat oder Diäthylsulfat, einem Aralkylhalogenid, wie Benzhydrylchlorid, ^enzylchlorid oder Phenäthylbromid oder einem Alkylarylsulfonat, wie Methyl-p-toluolsulfonat. Die ümaetsuxig wird vorzugsweise unter Erwärmen der Reaktionsteilnehmer in Gegenwart eines inerten Lösungsmittels, wie Aceto-The quaternary ammonium salts are obtained by reacting the free base with a quaternizing agent such as an alkyl halide such as methyl iodide, ethyl chloride or Isopropyl bromide, an alkenyl halide such as allyl chloride or allyl bromide, a dialkyl sulfate such as dimethyl sulfate or diethyl sulfate, an aralkyl halide such as benzhydryl chloride, ^ enzyl chloride or phenethyl bromide or an alkylarylsulfonate, such as methyl p-toluenesulfonate. The ümaetsuxig is preferably carried out with heating of the reactants in the presence of an inert solvent, such as aceto
909829/1572909829/1572
nitril, Aceton, Methanol oder Äthanol ausgeführt. Im allgemeinen scheidet sich das quaternäre Salz beim Abkühlen des Reaktionsgemische aus der Lösung ab und kann durch Filtrieren isoliert werden. Die Reinigung kann in üblicher Weise, zum Beiepiel durch Umkristallisieren, erfolgen.nitrile, acetone, methanol or ethanol. In general the quaternary salt separates out of the solution when the reaction mixture cools and can pass through Filtration can be isolated. The purification can be carried out in the usual way, for example by recrystallization.
Das Anion des erhaltenen quaternären Ammoniumsalzes kann gegen ein beliebiges anderes Anion ausgetauscht werden, z.B. gegen ein Anion einer der oben erwähnten Säurai Z.B. kann man ein quaternäres Ammoniumsalz, beispielsweise mit Silberoxyd, in das quaternäre Hydroxyd überführen und das so erhaltene Hydroxyd mit der gewünschten Säure umsetzen.The anion of the quaternary ammonium salt obtained can be exchanged for any other anion, e.g. against an anion of one of the acids mentioned above, e.g. a quaternary ammonium salt, for example with Silver oxide, converted into the quaternary hydroxide and the hydroxide thus obtained react with the desired acid.
Die folgenden Beispiele erläutern das erfindungsgemässe Verfahren.The following examples explain the invention Procedure.
Beispiel 1 1-(p-Hydroxy-phenyl)-2-phenyl_.6_methoxy-^,4-dihydro-naphthalin. Example 1 1- (p-hydroxy-phenyl) -2-me thoxy phenyl_.6_ - ^, 4-dihydro-naphthalene.
Eine Lösung von 5,83 g 2-Phenyl-6-methoxy-1,2,3,4-tetrahydro-1—naphthalinon in 75 ml Tetrahydrofuran wurde zu einer Tetrahydrofuranlösung gegeben, die 0,0247 Mol eines aus Magnesium und p-Bromphenol-tetrahydropyranyläther hergestellten Grignard-Reagenz enthielt. Das erhaltene Gemisch wurde 16 Stunden unter Rückfluss erhitzt, ^ann wurde gekühlt, mit 10 ml Wasser versetzt, filtriert und das FiI-trat mit Äther verdünnt. Die organische Schicht wurde abgetrennt, gut mit Wasser gewaschen und über wasserfreiem Natriumsulfat getrocknet. Die getrocknete Lösung wurde filtriert und das Piltrat unter vermindertem Druck zur '^rockene eingedampft. Der Rückstand wurde in 100 ml Tetrahydrofuran gelöst und nochmals mit dem obigen Grignard-Reagenz behandelt, Das Reaktionsgemiach aus der zweiten Grignardierung wurde wie im ersten Pail aufgearbeitet. Die erhaltene gummiartige Substanz wurde in 200 ml Benzol gelöst, dc;.s 200 mg p-Toluol~A solution of 5.83 g of 2-phenyl-6-methoxy-1,2,3,4-tetrahydro-1-naphthalenone in 75 ml of tetrahydrofuran was added to a tetrahydrofuran solution containing 0.0247 mol of a from magnesium and p-bromophenol tetrahydropyranyl ether prepared Grignard reagent. The received The mixture was refluxed for 16 hours cooled, mixed with 10 ml of water, filtered and the filtrate occurred diluted with ether. The organic layer was separated, washed well with water and dried over anhydrous Dried sodium sulfate. The dried solution was filtered and the piltrate was dried under reduced pressure evaporated. The residue was dissolved in 100 ml of tetrahydrofuran and treated again with the above Grignard reagent, The reaction mixture from the second Grignardation became processed as in the first pail. The obtained rubbery Substance was dissolved in 200 ml of benzene, i.e. 200 mg of p-toluene ~
9 0 9 8 2 9/15729 0 9 8 2 9/1572
sulfonsäure enthielt, und das Gemisch unter Verwendung eines Dean-Stark-Wasserfängers unter Rückfluss erhitzt, bis im Wasserfänger kein weiteres Wasser mehr aufgefangen wurde. Das Lösungsmittel wurde unter vermindertem Druck abdestilliert und darauf der Rückstand in einem Gemisch aus 200 ml Aceton und 70 ml 0,5 η-Salzsäure gelöst. Die Lösung wurde 2 Stunden bei Raumtemperatur (etwa 25 C) steheh gelassen und dann mit Äther extrahiert. Die organische Schicht wurde abgetrennt und mit 5 zeiger wässriger Kaiiumhydroxydlösung extrahiert. Der wässrige alkalische Extrakt wurde mit Salzsäure angesäuert und der sich abscheidende Feststoff abfiltriert und getrocknet. Er wurde in Methylenchlorid gelöst und über synthetisches Magnesium-Silikat chromatographiert. Die Säule wurde mit Hexankohlenwasserstoffen, die steigende Mengen Aceton enthielten, eluiert; diejenigen Fraktionen, die auf Grund des Infrarot-Spektrums oder papierchromatographischer Untersuchungen die gewünschte Verbindung enthielten, wurden zur Trolkene eingedampft, -^er Rückstand wurde zweimal aus Cyclohexan umkristallisiert. Man erhielt 0,71 g 1-(p-Hydroxyphenyl)-2-phenyl-6-methoxy-3,4-dihydro-naphthalin in Form eines kristallinen Feststoffes vom Schmelzpunkt 130 bis 131,5°C.sulfonic acid, and the mixture using a Dean-Stark water scavenger heated to reflux, until no more water was caught in the water catcher. The solvent became under reduced pressure distilled off and then the residue dissolved in a mixture of 200 ml of acetone and 70 ml of 0.5 η-hydrochloric acid. the The solution was left to stand for 2 hours at room temperature (about 25 ° C.) and then extracted with ether. The organic Layer was separated and made more aqueous with 5 pointers Extracted potassium hydroxide solution. The aqueous alkaline The extract was acidified with hydrochloric acid and the solid which separated out was filtered off and dried. He was in Dissolved methylene chloride and chromatographed over synthetic magnesium silicate. The column was filled with hexane hydrocarbons, containing increasing amounts of acetone, eluted; those fractions that are due to the infrared spectrum or paper chromatographic tests contained the desired compound, became Trolkene evaporated, - ^ he residue was twice from cyclohexane recrystallized. 0.71 g of 1- (p-hydroxyphenyl) -2-phenyl-6-methoxy-3,4-dihydro-naphthalene were obtained in the form of a crystalline solid from melting point 130 to 131.5 ° C.
Anal, berechnet für C2-H20O2: C 84,12; H 6,14; gefunden : C 83,64; H 5,96.Anal calcd for C 2 -H 20 O 2 : C 84.12; H 6.14; found: C, 83.64; H 5.96.
Beispiel 2 1-(p-Hydroxy-phenyl)-2-phenyl-6-(2-diäthylaminoäthoxy)-3,4-dihydro-naphthalin und dessen HydrochlorideExample 2 1- (p-Hydroxyphenyl) -2-phenyl-6- (2-diethylaminoethoxy) -3,4-dihydro-naphthalene and its hydrochloride
Zur Herstellung des Ausgangsstoffes, 2-Pnenyl-6-(2-diäthylaminoäthoxy)-1,2,3,4-tetrahydro-1-naphthalinon, wurde eine Suspension von 11,6 g 2-Phenyl-6-hydroxy-1,2,3,4-tetrahydro-1-naphthalinon, das man aus 2-Phenyl-6-methoxy-1,2,3,4-For the preparation of the starting material, 2-pnenyl-6- (2-diethylaminoethoxy) -1,2,3,4-tetrahydro-1-naphthalenone, was a suspension of 11.6 g of 2-phenyl-6-hydroxy-1,2,3,4-tetrahydro-1-naphthalenone, from 2-phenyl-6-methoxy-1,2,3,4-
909829/1572909829/1572
BAOBAO
tetrahydro-1-naphthalinon mit Aluminiumbromid in Benzol (Journ. Chem. Soc. Bd. 82, S. 5205, 1960) erhalten hatte, in 200 ml Methanol mit 10 ml 4,8 η iJatriummethylatlösung behandelt. Das Gemisch wurde 15 Minuten gerührt und dann mit 13,2 g eines 1ii-^emicches aus 2-Diäthylaminoäthylchlorid und Toluol versetzt. Das erhaltene Gemisch wurde 17 Stunden unter Rückfluss erhitzt und darauf das Lösungsmittel unter vermindertem 1WcIc entfernt. Der Rückstand wurde mit einem Gemisch aus rtasser und Methylenchlorid behandelt, die organische Schicht abgetrennt, mit rtasser und dann mit Salzlösung gewaschen und zur Trockene eingedampft. Der Rückstand wurde in 40 ml Äthanol gelöst und mit 120 ml gesättigter äthanolischer Pikrinsäure behandelt. Der sich abscheidende Peststoff wurde abfiltriert und aus Acetonitril umkristallisiert. Man erhielt 13,15 g 2-Phenyl-6-(2-diäthylaminoäthoxy)-1,2,3,4-tetrahydro-1-naphthalinon in Form des Pikrats; F = 180-184°C, Durch weiteres Umkristallisieren aus dem gleichen Lösungsmittel wurde eine Analysenprobe vom Schaelzpunkt 185-1860G erhalten.tetrahydro-1-naphthalenone with aluminum bromide in benzene (Journ. Chem. Soc. Vol. 82, p. 5205, 1960) treated in 200 ml of methanol with 10 ml of 4.8% sodium methylate solution. The mixture was stirred for 15 minutes and then 13.2 g of a 1ii- ^ emicches from 2-diethylaminoethyl chloride and toluene were added. The resulting mixture was refluxed for 17 hours and then the solvent was removed under reduced 1 WcIc. The residue was treated with a mixture of rt ater and methylene chloride, the organic layer separated, washed with ater rt and then washed with brine and evaporated to dryness. The residue was dissolved in 40 ml of ethanol and treated with 120 ml of saturated ethanolic picric acid. The pesticide which separated out was filtered off and recrystallized from acetonitrile. 13.15 g of 2-phenyl-6- (2-diethylaminoethoxy) -1,2,3,4-tetrahydro-1-naphthalenone were obtained in the form of the picrate; F = 180-184 ° C, an analytical sample was obtained from Schaelzpunkt 185-186 0 G By further recrystallization from the same solvent.
Anal, berechnet fürAnal calculated for
gefunden:found:
C 59,36; H 5,34; N 9,89; C 59,18; H 5,45; W 9,99.C 59.36; H 5.34; N 9.89; C 59.18; H 5.45; W 9.99.
Ein Gemisch aus 7,46 g des Pikrats, 50 ml Methylenchlprid und 50 ml etwa 14'^iger Ammoniumhydroxydlösung wurde bei Raumtemperatur 2 Stunden geschüttelt. Die organische Schicht wurde abgetrennt, einmal mit wässrigem Ammoniak, dann mit Wasser und darauf mit Kochsalzlösung gewaschen und zur Trokkene eingedampft. Dem aus 7,70 g des Tetr^hydropyranyläthers von p-Bromphenol und 0,73 g Magnesium in 80 ml Tetrahydrofuran erhaltenen Grignard-Reagenz setzte man eine Lösung des Rückstandes in 50 rnl Tetrahydrofuran zu. Das erhaltene Gemisch wur<le 17 Stunden unter Rückfluss erhitzt, dann gekühlt und durch vorsichtige Zugabe von wasser zersetzt.A mixture of 7.46 g of the picrate, 50 ml of methylene chloride and 50 ml of about 14% ammonium hydroxide solution was shaken at room temperature for 2 hours. The organic layer was separated, washed once with aqueous ammonia, then with water, then with brine and evaporated to dryness. A solution of the residue in 50 ml of tetrahydrofuran was added to the Grignard reagent obtained from 7.70 g of the tetrahydropyranyl ether of p-bromophenol and 0.73 g of magnesium in 80 ml of tetrahydrofuran. The resulting mixture WUR <le 17 hours under reflux, then cooled and decomposed by careful addition of w ater.
BAD ORIGINALBATH ORIGINAL
909829/1572909829/1572
Das erhaltene Gemisch wurde filtriert und das Filtrat mit Äther verdünnt. Die organische Schicht wurde abgetrennt, gut mit Wasser gewaschen und über wasserfreiem Natriumsulfat getrocknet. Die getrocknete Lösung wurde filtriert und das Filtrat unter vermindertem Druck zur Trockene eingedampft. Der Rückstand wurde in 100 ml Tetrahydrofuran gelöst und, wie oben beschrieben, nochmals mit dem ^"rignard-Reagenz behandelt. Das Reaktionsgemisch aus der .zweiten Grignardierung wurde wie im ersten i'all aufgearbeitet. Der erhaltene gummiartige Rückstand wurde in 150 ml 2,5 n-Salzsäure suspendiert. Der abgeschiedene Feststoff wurde abfiitriert und aus einem Gemisch von Methanol und 2,5 n-Salzsäure und nachfolgend aus einem Gemisch von Methanol und Acetonitril umkristallisiert. Man erhielt 3,20 g 1 — (p-Hydroxy-phenyl)-2-phenyl-6-(2-diäthylaminoäthoxy)-3,4— dihydro-naphthalin-hydrochlorid vom Schmelzpunkt 232-236 C. Durch weiteres Umkristallisieren aus dem gleichen Lösungs— mittelgemisch erhielt man eine Analysenprobe vom Schmelzpunkt 232-235,5°C.The resulting mixture was filtered and the filtrate with Ether diluted. The organic layer was separated, washed well with water and over anhydrous sodium sulfate dried. The dried solution was filtered and the filtrate was evaporated to dryness under reduced pressure. The residue was dissolved in 100 ml of tetrahydrofuran and, as described above, again with the Rignard reagent treated. The reaction mixture from the second Grignardation was worked up as in the first i'all. The obtained gummy residue was dissolved in 150 ml of 2.5N hydrochloric acid suspended. The deposited solid was filtered off and from a mixture of methanol and 2.5N hydrochloric acid and subsequently from a mixture of methanol and acetonitrile recrystallized. 3.20 g of 1 - (p-Hydroxyphenyl) -2-phenyl-6- (2-diethylaminoethoxy) -3,4- dihydro-naphthalene hydrochloride with a melting point of 232-236 C. Further recrystallization from the same solvent mixture gave an analytical sample with a melting point 232-235.5 ° C.
Anal, berechnet für C28H32ClNO2: C 74,73; H 7,17; Cl 7,88; gefunden : C 74,21; H 7,35} Cl 7,96.Anal calcd for C 28 H 32 ClNO 2 : C 74.73; H 7.17; Cl 7.88; Found: C, 74.21; H 7.35} Cl 7.96.
Eine Suspension von 1 g des erhaltenen Hydrochloride in 50 ml Äther wurde mit wässriger Natriumbicarbonatlösung geschüttelt, die Ätherschicht abgetrennt und zur trockene eingedampft, worauf man das freie i-(p-Hydroxy-phenyl)-2-phenyl-6-(2-diäthylaminoäthoxy)-3,4-dihydro-naphthalin erhielt.A suspension of 1 g of the hydrochloride obtained in 50 ml of ether was treated with aqueous sodium bicarbonate solution shaken, the ether layer separated and evaporated to dryness, whereupon the free i- (p-hydroxyphenyl) -2-phenyl-6- (2-diethylaminoethoxy) -3,4-dihydro-naphthalene received.
Das in Beispiel 1 und 2 verwendete 2-Phenyl-6-methoxy-1,2,3,4-tetrahydro-1-naphthalinon wurde wie folgt hergestellt:The 2-phenyl-6-methoxy-1,2,3,4-tetrahydro-1-naphthalenone used in Examples 1 and 2 was made as follows:
Eine Lösung von 45 g m-Methoxy-acetophenon in 75 ml 95 tigern Äthanol wurde zu einer gekühlten Lösung von 16 gA solution of 45 g of m-methoxy-acetophenone in 75 ml of 95% ethanol became a cooled solution of 16 g
909829/1572909829/1572
BADBATH
H93323H93323
Natriumhydroxyd in 140 ml Wasser gegeben. Das uemiüch wurde darauf in ein Eisbad gestellt und mit 31 »8 g benzaldehyd in solcher Geschwindigkeit versetzt, dass die temperatur unterhalb 30 0 blieb. Nach der Zugabe wurde noch 30 Minuten in der Kälte gerührt und dann 27 Stunden bei etwa 250C Die erhaltene Lösung wurde mit Äther extrahiert, der Extrakt mit gesättigter Natriumchloridlösung gewaschen, dann durch wasserfreies Magnesiumsulfat percoliert und bei vermindertem Druck zur Trockene eingedampft. Wan erhielt 50,9 g 3!-Methoxy-chalkon in Form eines Öls; Kp. bei 4 mm Hg 180-185°C.Sodium hydroxide is added to 140 ml of water. The U emiüch was put out in an ice bath, and 31 "8 g benzaldehyde are added at such a rate that the temperature below 30 0 remained. After the addition, the mixture was stirred in the cold for 30 minutes and then at about 25 ° C. for 27 hours. The solution obtained was extracted with ether, the extract was washed with saturated sodium chloride solution, then percolated through anhydrous magnesium sulfate and evaporated to dryness under reduced pressure. Wan received 50.9 g 3 ! -Methoxy-chalcone in the form of an oil; Bp at 4 mm Hg 180-185 ° C.
Zu einer Mischung aus 50,9 g 3'-Methoxy-chalcon, 13,0 g Essigsäure und 100 ml 95$igem Äthanol wurde innerhalb von 10 Hinuten eine Lösung von 27»8 g ^aliumcyanid in 50 ml Wasser gegeben. Dabei hielt man die Temperatur auf 45 C. Dann wurde 6 Stunden gerührt und über ^acht in der Kälte stehen gelassen. Der ausgefallene Peststoff wurde abfiltriert, mit eiskaltem wässrigen Äthanol und mit Wasser gewaschen und aus Äthanol umkristallisiert, Man erhielt 49,22 g 2-Phenyi„4_(3'-methoxy-phenyl)-4-keto-butyronitril in Form eines kristallinen Feststoffes vom Schmelzpunkt 96-101 C. Das IR-Spektrum der Verbindung in Mineralöl zeigte Maxima bei 2200, 1660 und 1580 cm"1.A solution of 27.8 g of aluminum cyanide in 50 ml of water was added over a period of 10 minutes to a mixture of 50.9 g of 3'-methoxy chalcone, 13.0 g of acetic acid and 100 ml of 95% ethanol. The temperature was kept at 45 ° C. The mixture was then stirred for 6 hours and left to stand in the cold for more than eight hours. The precipitated pesticide was filtered off, washed with ice-cold aqueous ethanol and with water and recrystallized from ethanol. 49.22 g of 2-phenyl 4_ (3'-methoxyphenyl) -4-keto-butyronitrile were obtained in the form of a crystalline solid from Melting point 96-101 C. The IR spectrum of the compound in mineral oil showed maxima at 2200, 1660 and 1580 cm " 1 .
Eine Suspension von 49,22 g 2-Fhenyl-4-(3'-methoxyphenyl)-4-keto-butyronitril in einer Mischung aus 140 ml konzentrierter Schwefelsäure und 125 ml Wasser wurde auf dem dampfbad unter heftigem Rühren 4 Stunden erhitzt. Das erhaltene üemiych wurde gekühlt und mit Eiswasser verdünnt. Der abgeschiedene Feststoff wurie abfiltriert und aus wässrigem Äthanol und danach aus Benzol umkristallisiert, wan erhielt 29,5 g 2-Ihenyl-4-(3'-methoxyphenyl)-4-keto-buttersäure in Form eines kristallinen Feststoffes vom Schmelzpunkt 14O-145°C. Eine Analysenprobe, die durch Umkristal-A suspension of 49.22 g of 2-phenyl-4- (3'-methoxyphenyl) -4-keto-butyronitrile in a mixture of 140 ml of concentrated sulfuric acid and 125 ml of water was heated on the steam bath with vigorous stirring for 4 hours. The UE emiych obtained was cooled and diluted with ice water. The deposited solid was filtered off and recrystallized from aqueous ethanol and then from benzene, giving 29.5 g of 2-phenyl-4- (3'-methoxyphenyl) -4-keto-butyric acid in the form of a crystalline solid with a melting point of 140-145 ° C. An analysis sample that is
BAD 909829/1572BATH 909829/1572
lisieren aus Benzol erhalten wurde, schmolz bei 143-145 C·was obtained from benzene, melted at 143-145 C
Anal, berechnet für C17H16O4: C 71,82; H 5,67; gefunden : C 72,10; H 5,74.,Anal calcd for C 17 H 16 O 4 : C, 71.82; H 5.67; found: C, 72.10; H 5.74.,
3OO g Zinkschwamm wurden kurz mit 2,5 η-Salzsäure und dann mit Wasser gewaschen, ^as Metall wurde darauf mit einer Lösung von 6,7 g Quecksilberchlorid in 500 ml Wasser bedeckt und das Gemisch 30 Minuten unter gelegentlichem Schütteln stehen gelassen. Die flüssige Phase wurde abdekantiert und das amalgamierte Metall gut mit Wasser gewaschen. Dem amalgamierten Zink wurde eine Mischung aus 29,3 g 2-Phenyl-4-(3'-methoxy-phenyl)-3-keto-buttersäure und 400 ml Salzsäure zugegeben, ^ann wurde vorsichtig auf Rückflusstemperatur gebracht und insgesamt 20 Stunden unter Rückfluss erhitzt, wobei nach 5 und 10 Stunden weitere Salzsäure zugesetzt wurde. Das erhaltene Gemisch wurde gekühlt, darauf die Flüssigkeit vom Peststoff abdekantiert, der'feste Rückstand gut mit Äther gewaschen und die abdekantierte Flüssigkeit mit Äther extrahiert. Der Ätherextrakt und die Waschflüssigkeit wurden vereinigt und mit "asser und darauf mit gesättigter Natriumchloridlösung gewaschen. Dann wurde durch wasserfreies Magnesiumsulfat percoliert. Das Percolat wurde zur '-Trockne eingedampft. Man erhielt 25,2 g 2-Phenyl-4-(3'-methoxyphenyl)-buttersäure in Form eines viskosen Öls, das ohne weitere Reinigung weiterverarbeitet wurde. Das IR-Spektrum der Verbindung (in Mineralöl) zeigte ein Maximum bei 1705 cm"* ·300 g of zinc sponge were washed briefly with 2.5 η hydrochloric acid and then with water, the metal was then covered with a solution of 6.7 g of mercury chloride in 500 ml of water and the mixture was left to stand for 30 minutes with occasional shaking. The liquid phase was decanted off and the amalgamated metal was washed well with water. A mixture of 29.3 g of 2-phenyl-4- (3'-methoxyphenyl) -3-keto-butyric acid and 400 ml of hydrochloric acid was added to the amalgamated zinc, and the mixture was carefully brought to reflux temperature and refluxed for a total of 20 hours heated, further hydrochloric acid was added after 5 and 10 hours. The mixture obtained was cooled, the liquid was then decanted off from the pesticide, the solid residue was washed well with ether and the decanted liquid was extracted with ether. The ether extract and the washing liquid were combined and washed with water and then with saturated sodium chloride solution. Then percolation was carried out with anhydrous magnesium sulfate. The percolate was evaporated to dryness. 25.2 g of 2-phenyl-4- (3'- methoxyphenyl) butyric acid in the form of a viscous oil, which was processed further without further purification. The IR spectrum of the compound (in mineral oil) showed a maximum at 1705 cm "*
In 150 ml flüssigen Fluorwasserstoff wurden unter kühlen und Schütteln 26,2 g 2-i?henyl-4-( 3'-methoxy-phenyl)-buttersäure gegeben. Das erhaltene üemisch wurae 3 -age bei Raumtemperatur stehen gelassen, ^er Rückstand wurde in Methylen-Chlorid gelöst und die Lösung in überschüssige konzentrierte26.2 g of 2-i? Henyl-4- (3'-methoxyphenyl) butyric acid were added to 150 ml of liquid hydrogen fluoride with cooling and shaking. The üemisch obtained wurae 3 -age at room temperature allowed to stand ^ he was dissolved in methylene chloride residue and the solution concentrated in excess
909829/1572 bad Original909829/1572 bad original
wässrige Natriumcarbonatlösung gegossen. Die organische Schicht wurde abgetrennt, mit Wasser und gesättigter Natriumchloridlösung gewaschen und dann zur x'rockne eingedampft. Der Rückstand wurde in 2 1 Hexankohlenwasserstoffen, die 7» 5 "Volum % Aceton enthielten, gelöst und die Lösung über eine Säule aus synthetischem Kagnesiumsilikat chroma— tographiert, die mit dem gleichen Lösungrjmittelgemi.ich vorgewaschen worden war, Das Eluat wurde zur Trockne eingedampft und der Rückstand (17,0 g) zweimal aus Cyclohexan umkristallisiert, nan erhielt 13,38 g 2--chenyl-6-methoxy-1,2, 3,4-tetrahydro~1-naphthalinon in .Form einer kristallinen Verbindung vom Schmelzpunkt 113-1160C,Poured aqueous sodium carbonate solution. The organic layer was separated, washed with water and saturated sodium chloride solution and then the x 'Rockne evaporated. The residue was dissolved in 2 liters of hexane hydrocarbons containing 7-5 "% by volume of acetone, and the solution was chromatographed on a column of synthetic magnesium silicate which had been prewashed with the same mixture of solvents. The eluate was evaporated to dryness and the residue (17.0 g) recrystallized twice from cyclohexane, giving 13.38 g of 2-chenyl-6-methoxy-1,2,3,4-tetrahydro-1-naphthalenone in the form of a crystalline compound with a melting point of 113 -116 0 C,
Anal, berechnet für c-|7H-|b°2! c ^°»92; II 6,39; gefunden : C 81,08; H 6,35.Anal, calculated for c - | 7 H - | b ° 2 ! c ^ ° »92; II 6.39; Found: C, 81.08; H 6.35.
909829/1572909829/1572
Claims (2)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29276763A | 1963-07-03 | 1963-07-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE1493323A1 true DE1493323A1 (en) | 1969-07-17 |
| DE1493323B2 DE1493323B2 (en) | 1973-04-26 |
Family
ID=23126105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19641493323 Pending DE1493323B2 (en) | 1963-07-03 | 1964-06-25 | 1- (P-HYDROXYPHENYL) -2-PHENYL-6METHOXY-3,4-DIHYDRONAPHTHALIN, ITS PHARMACOLOGICALLY APPROPRIATE SALT AND METHOD FOR PREPARING THESE COMPOUNDS |
Country Status (6)
| Country | Link |
|---|---|
| BE (1) | BE650081A (en) |
| CH (1) | CH456579A (en) |
| DE (1) | DE1493323B2 (en) |
| FR (1) | FR1568704A (en) |
| GB (1) | GB1068751A (en) |
| NL (1) | NL6407603A (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9522615D0 (en) * | 1995-11-03 | 1996-01-03 | Pharmacia Spa | 4-Phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity |
| US5863915A (en) * | 1996-05-15 | 1999-01-26 | Bayer Corporation | Substituted 4-arylbutyric acid derivatives as matrix metalloprotease |
| ZA974033B (en) * | 1996-05-15 | 1998-02-19 | Bayer Ag | Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors. |
| FI20011507A0 (en) * | 2001-07-10 | 2001-07-10 | Orion Corp | New compounds |
| FI20030030A0 (en) | 2003-01-09 | 2003-01-09 | Orion Corp | New compounds |
-
0
- BE BE650081D patent/BE650081A/xx unknown
-
1964
- 1964-06-17 CH CH795664A patent/CH456579A/en unknown
- 1964-06-18 GB GB25300/64A patent/GB1068751A/en not_active Expired
- 1964-06-25 DE DE19641493323 patent/DE1493323B2/en active Pending
- 1964-07-02 FR FR1568704D patent/FR1568704A/fr not_active Expired
- 1964-07-03 NL NL6407603A patent/NL6407603A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR1568704A (en) | 1969-05-30 |
| NL6407603A (en) | 1965-01-04 |
| BE650081A (en) | |
| DE1493323B2 (en) | 1973-04-26 |
| CH456579A (en) | 1968-07-31 |
| GB1068751A (en) | 1967-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1493346A1 (en) | Derivatives of therapeutically active benzene condensation products and processes for their preparation | |
| DE2635276A1 (en) | TETRAHYDROISOCHINOLINE DERIVATIVES, THE PROCESS FOR THEIR PRODUCTION AND MEDICINAL PREPARATIONS CONTAINING THESE COMPOUNDS | |
| DE1493374A1 (en) | 1,2-diphenyl-3,4-dihydronaphthalene and 2,3-diphenylindene derivatives and processes for their preparation | |
| DE2215779A1 (en) | Monounsaturated monohydric amino alcohols | |
| DE2047658A1 (en) | ||
| DE1493340A1 (en) | Dihydronaphthalenes and processes for their preparation | |
| CH633249A5 (en) | METHOD FOR PRODUCING NEW POLYPRENYL DERIVATIVES. | |
| DE1493323A1 (en) | 1,2-Diphenyl-3,4-dihydronaphthalenes and their acid addition salts and quaternary ammonium compounds | |
| CH622239A5 (en) | ||
| EP0005821A1 (en) | Indanamine derivatives, process for their preparation and medicaments containing them | |
| DE2704690C2 (en) | Triphenylalkene derivatives, processes for their preparation and medicaments containing them | |
| DE2840786C2 (en) | ||
| CH629776A5 (en) | METHOD FOR PRODUCING NEW PHENYLAZACYCLOAL CHANES. | |
| DE1670386A1 (en) | New cyclohexane derivatives and processes for their preparation | |
| DE1695962A1 (en) | (2-aminocycloalkyl) hydroquinones and derivatives thereof and processes for their preparation | |
| DE1695963A1 (en) | Cycloalkenamine-p-benzoquinone adducts and processes for their preparation | |
| CH435249A (en) | Process for the preparation of dihydronaphthalenes | |
| EP0037062B1 (en) | Substituted 3-aryl-2-cycloalkene-1-ones, process for their preparation and their parmaceutical use | |
| DE2747987C2 (en) | ||
| DE1493282C (en) | 1 square bracket on P (2 tert Aminoathoxy) phenyl square bracket on 2 phenyl 6 methoxy 3,4 dihydronaphtha faucets and process for their preparation | |
| DE1620305A1 (en) | Process for the preparation of 3-aminoisoxazole derivatives | |
| EP0102929B1 (en) | Propylamine derivatives, process for their preparation, pharmaceutical compositions containing these compounds, and their therapeutical use | |
| DE1493366A1 (en) | Naphthalene derivatives and processes for their preparation | |
| DE1668763A1 (en) | Process for the preparation of diaryl-6-methoxy-1,2,3,4-tetrahydro-1,2-naphthalenediols | |
| DE1695944A1 (en) | Process for the production of new 1,3-amino alcohols |